Parkinson's Disease Clinical Trials in San Antonio

Showing 21-40 of 103 trials

Endurance Exercise & Virtual Reality for Optimizing Cortical Excitability and Neuroplasticity in PD

NCT06133283

This study aims to determine the effects of aerobic exercise as a primer to add-on virtual reality (VR)-based rehabilitation on balance, postural control and neuroplasticity (ability of brain to adapt in structure and function) in individuals with Parkinson's disease (PD). This study will utilize two groups - one group will receive the exercise and VR, while the other group will receive stretching exercise and VR over eight weeks. The study team will administer outcomes at baseline, post-intervention (8 weeks) and follow-up (6 weeks after post-assessment).

Parkinson Disease

The University of Texas Health Science Center at San Antonio16 participantsStarted Feb 2024

San Antonio, Texas, United States

RECRUITING< 1 mile

Parkinson's Foundation PD GENEration Genetic Registry

NCT04994015

Development of a central repository for PD-related genomic data for future research.

Parkinson's Disease

Parkinson's Foundation25,000 participantsStarted Dec 2020

Birmingham, Alabama, United States • Chandler, Arizona, United States • Phoenix, Arizona, United States +53 more locations

Endurance Exercise & Virtual Reality for Optimizing Cortical Excitability and Neuroplasticity in PD

Parkinson's Foundation PD GENEration Genetic Registry

Parkinson's Disease Trials in Other Cities

A Study to Evaluate the Safety and Tolerability of ABBV-951 in Subjects With Parkinson's Disease (PD)

Posiphen® Dose-Finding, Biomarker Study in Early Alzheimer's and Parkinson's Patients

A Double-blind Study to Investigate Efficacy and Safety of Buntanetap Compared With Placebo in Participants With Early PD

A Study of TAK-071 in People With Parkinson Disease

STEM-Parkinson's Disease

Clinical Outcome Assessment of Parkinson's Disease Patients Treated With XADAGO (Safinamide)

STEM-PD Open Label Extension (OLE)

Wearable Assessments in the Clinic and Home in PD

Clinical Evaluation of the Infinity Deep Brain Stimulation System

Orally Administered ENT-01 for Parkinson's Disease-Related Constipation (KARMET)

Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's Disease

PDGeneration: Mapping the Future of Parkinson's Disease

Open-Label Study With Pimavanserin on Activities of Daily Living in Subjects With Parkinson's Disease Psychosis

Visualization of the STN and GPi for DBS

Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease

Deep Brain Stimulation (DBS) for the Treatment of Parkinson's Disease

Orally Administered ENT-01 for Parkinson's Disease-Related Constipation Follow-on Safety "Roll-over" Study (Rollover)

Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation

Other Conditions in San Antonio